Berger Montague PC is investigating C3.ai Inc. (NYSE: AI), a California-based enterprise artificial intelligence software provider, on behalf of investors who purchased shares from February 26, 2025, to August 8, 2025. The investigation centers around allegedly false statements about the company's growth prospects and CEO health impact. Following disappointing Q1 financial results and reduced revenue guidance in August 2025, C3.ai's stock price plummeted by over 25% from $22.13 to $16.47 per share.